Palogic Value Management »

Regenxbio Inc equity us cm shares owned by Palogic Value Management

Quarter-by-quarter ownership of Regenxbio Inc equity us cm (RGNX) shares owned by Palogic Value Management from 13F filings

Historical chart of Palogic Value Management investment in Regenxbio Inc equity us cm

Tip: Access up to 7 years of quarterly data

All positions including Regenxbio Inc equity us cm held by Palogic Value Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regenxbio Inc equity us cm by Palogic Value Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $251k 30k 8.38

More positions owned by Palogic Value Management

Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Exxon Mobil Corporation (XOM)
Ssga Active Etf Tr State Street Bla (SRLN)
Bhp Billiton Sponsored Ads (BHP)
Microsoft Corporation (MSFT)
Open Lending Corp (LPRO)
Spdr Series Trust State Street Spd (BIL)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Nuveen Insured Tax-Free Adv Munici (NEA)
Abbvie (ABBV)
Shell Spon Ads (SHEL)
Amazon (AMZN)
Health Catalyst (HCAT)

View all positions for Palogic Value Management

Top funds holding Regenxbio Inc equity us cm

BlackRock
Redmile Group
State Street Corporation
Morgan Stanley
Vanguard Capital Management
Goldman Sachs Group
Integral Health Asset Management
Qube Research & Technologies
Geode Capital Management
AQR Capital Management
Vanguard Portfolio Management
Dimensional Fund Advisors
Nuveen
Two Sigma Investments
Pale Fire Capital SE

View all funds holding Regenxbio Inc equity us cm